Pharming Group N.V. (AMS:PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	600	627	690	707	503	812
Market Cap Growth	-22.70%	-9.08%	-2.41%	40.66%	-38.05%	-17.99%
Enterprise Value	612	587	658	657	487	787
Last Close Price	0.88	0.93	1.03	1.08	0.78	1.27
PE Ratio	-	-	-	55.27	35.75	26.30
Forward PE	-	-	163.65	27.10	16.92	15.76
PS Ratio	2.02	2.19	3.11	3.68	2.88	4.68
PB Ratio	3.01	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	8.63	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	127.40	-	-	35.85	21.10	12.57
P/OCF Ratio	106.63	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.06	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	35.11	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	55.16	-	-	67.70	23.07	12.62
EV/FCF Ratio	129.98	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.55	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	5.86	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	23.40	-	-	7.91	5.97	2.05
Asset Turnover	0.76	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.61	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.00	2.96	3.28	3.90	4.69	3.09
Current Ratio	2.76	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	-6.78%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	1.99%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Capital (ROIC)	2.38%	-0.62%	-3.57%	1.79%	4.29%	18.30%
Return on Capital Employed (ROCE)	4.10%	-	-	2.80%	6.80%	22.30%
Earnings Yield	-2.18%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	0.78%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	-2.22%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.